Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies
Natalia Khalaf, Chen Yuan, Tsuyoshi Hamada, et al.
Gastroenterology (2017) Vol. 154, Iss. 5, pp. 1380-1390.e5
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Use of Nonsteroidal Anti-Inflammatory Drugs and Pancreatic Cancer Risk in the Women’s Health Initiative
Theodore M. Brasky, Leah R. Jager, Alison M. Newton, et al.
Cancer Epidemiology Biomarkers & Prevention (2024) Vol. 33, Iss. 9, pp. 1203-1210
Closed Access | Times Cited: 1
Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis
Elise Pretzsch, Jan D’Haese, Bernhard W. Renz, et al.
BMC Surgery (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 9
The Epidemiology of Pancreatic Cancer and the Association With Acetylsalicylic Acid in the United States
George Khoudari, Motasem Alkhayyat, Mohannad Abou Saleh, et al.
Pancreas (2020) Vol. 49, Iss. 9, pp. 1207-1212
Closed Access | Times Cited: 9
Aspirin Use and Risk of Pancreatic Ductal Adenocarcinoma: A Large Case-Control Study
Zahra Momayez Sanat, Sahar Masoudi, Seidamir Pasha Tabaeian, et al.
Archives of Iranian Medicine (2023) Vol. 26, Iss. 4, pp. 181-185
Open Access | Times Cited: 3
Can aspirin use reduce the risk of pancreatic cancer: an updated systematic review and meta-analysis
Dong Wu, Bin Zhou, Jian Yang, et al.
Journal of Pancreatology (2020) Vol. 3, Iss. 4, pp. 201-210
Open Access | Times Cited: 7
HPLC Method for Determination of Aspirin, Rosuvastatin, Ezetimibe and Clopidogrel in Combination Drug Products
Suresh Kumar Palacharla, G.V. Krishna Mohan
Asian Journal of Chemistry (2019) Vol. 31, Iss. 10, pp. 2275-2283
Open Access | Times Cited: 6
Can Aspirin Use Be Associated With the Risk or Prognosis of Bladder Cancer? A Case-Control Study and Meta-analytic Assessment
Bo Fan, Alradhi Mohammed, Yuanbin Huang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 5
Aspirin Does Not Prevent Pancreatic Cancer in a Large Asian Cohort
Min Hyung Kim, Sang Min Park, Young Ho Yun, et al.
Cancer Epidemiology Biomarkers & Prevention (2019) Vol. 28, Iss. 4, pp. 826-828
Closed Access | Times Cited: 3
Cyclooxygenase-2 and Cytosolic Phospholipase A2 Are Overexpressed in Mucinous Pancreatic Cysts
Elsie T. Mensah, Thomas C. Smyrk, Lizhi Zhang, et al.
Clinical and Translational Gastroenterology (2019) Vol. 10, Iss. 4, pp. e00028-e00028
Open Access | Times Cited: 3
Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma
Katherine Chung, Jaffarguriqbal Singh, Lauren Lawres, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 3
Pancreatic and Biliary Tract Cancers
Alexander Ney, Daniel Osei‐Bordom, Andrés García-Sampedro, et al.
(2024), pp. 291-320
Closed Access
Clinical evaluation of side effects resulting from the use of aspirin cardio
Meraim A. Kazaal, Ghanim A. Abbas, Masar J. AL-Kurdy, et al.
AIP conference proceedings (2024) Vol. 3092, pp. 030004-030004
Open Access
Re: NSAID Use and Pancreatic Cancer Risk
Harvey A. Risch
Gastroenterology (2018) Vol. 155, Iss. 3, pp. 931-931
Closed Access | Times Cited: 2
The Positive Feedback Loop Between Inflammation and Mutant KRAS Genes Promotes Malignant Transformation in Chronic Pancreatitis
Fan Yang, Lei Li, Xiangyu Kong
Cancer Screening and Prevention (2022) Vol. 1, Iss. 1, pp. 39-46
Open Access | Times Cited: 2
Stories of drug repurposing for pancreatic cancer treatment—Past, present, and future
Matthias Ilmer, Maximilian Weniger, Hanno Nieß, et al.
Elsevier eBooks (2020), pp. 231-272
Closed Access | Times Cited: 2
Proteomic Characterization of Circulating Molecular Perturbations Associated With Pancreatic Adenocarcinoma Following Intravenous ω‐3 Fatty Acid and Gemcitabine Administration: A Pilot Study
Franscois Runau, Ali Arshad, John Isherwood, et al.
Journal of Parenteral and Enteral Nutrition (2020) Vol. 45, Iss. 4, pp. 738-750
Open Access | Times Cited: 1
The Role of Circulating Protein and Metabolite Biomarkers in the Development of Pancreatic Ductal Adenocarcinoma (PDAC): A Systematic Review and Meta-analysis
Swati Kumar, Ralph Santos, Andrew McGuigan, et al.
Cancer Epidemiology Biomarkers & Prevention (2021) Vol. 31, Iss. 5, pp. 1090-1102
Open Access | Times Cited: 1
No risk from aspirin in pancreatic cancer
Iain Dickson
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 2, pp. 68-68
Closed Access
Reply
Natalia Khalaf, Chen Yuan, Yin Cao, et al.
Gastroenterology (2018) Vol. 155, Iss. 3, pp. 931-932
Open Access
Author's Reply to: “Design flaws in statins and pancreatic cancer research” (IJC‐19‐0941)
Jakob Kirkegård, Jennifer L. Lund, Frank Viborg Mortensen, et al.
International Journal of Cancer (2019) Vol. 145, Iss. 5, pp. 1450-1451
Open Access
Previous Page - Page 2

Scroll to top